UK maker of PEEK, a high-performance polymer used in aerospace, medical implants, automotive and electronics.
UK maker of PEEK, a high-performance polymer used in aerospace, medical implants, automotive and electronics.
Sells PEEK by weight to makers of components, with the medical grade sold through its Invibio unit, where each grade is qualified for implants over years and repeat orders follow. The company began as the ICI chemicals group's PEEK business before a 1990s buyout and listing.
In one line: The world's leading PEEK polymer producer.
Moat: wide (IP / patents, process know-how, scale). Global leader in patented PEEK manufacturing with decades of process know-how.
Headquarters: Thornton-Cleveleys, UK · Founded: 1993 · Employees: 1,169
Size Victrex (VCT.L) is a United Kingdom Materials company (Chemicals: Major Diversified) with a market value of $1.06B, the 210th largest of 355 United Kingdom companies the cockpit tracks. Shares closed at £922.00 on 18 Nov 2026.
Performance Over six months the shares gained 45.7%, against -32.9% for the median peer and +0.1% for the United Kingdom market (cap-weighted) — 2nd highest of 21 in its peer set.
Growth Revenue fell 1.2% over the last twelve months (peer median +4.1%); the operating margin is 14.3% (peer median 10.2%).
Valuation It trades at 22.5× forward earnings against a peer median of 21.1× (4th most expensive of 14).
Price implies For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +2%, so the hurdle is +15 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 2.7 points below its cost of capital (11.2% WACC).
Next results Next results expected around 8 Dec 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | £294M | £293M | £291M | £307M | £341M |
| Revenue growth | — | +1% | -5% | -10% | — |
| Gross profit | £126M | £128M | £138M | £168M | £175M |
| EBITDA | £66.9M | £70.3M | £90.4M | £111M | £121M |
| Net income | -£19.7M | £27.8M | £17.2M | £61.7M | £76.2M |
| Free cash flow | £48.0M | £48.4M | £50.3M | £2.30M | £34.5M |
| Capital expenditure | £20.6M | £21.8M | £32.6M | £38.5M | £45.5M |
| Total debt | n/a | £49.0M | £50.4M | £50.2M | £32.1M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Victrex VCT.L | $1.06B | +46% | -1% | 14% | 22.5× | 16.7% |
| Evonik Industries EVK.DE | $11.1B | +27% | +2% | 10% | 12.1× | -5.6% |
| Celanese CE | $5.29B | -10% | +1% | 9% | 7.8× | 6.0% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | VCT.L | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +1.3% | -12.8% | 5th highest of 21 |
| 6-month return | +45.7% | -32.9% | 2nd highest of 21 |
| Distance from 52-week high | -10.0% | -48.8% | 3rd highest of 21 |
| Revenue growth (TTM) | -1.2% | +4.1% | 8th lowest of 21 |
| Operating margin | 14.3% | 10.2% | 9th highest of 21 |
| Forward P/E | 22.5× | 21.1× | 4th most expensive of 14 |
| Growth the price implies (Req g, 7 yrs) | 16.7% | 7.1% | 5th most demanding of 12 |
| Growth delivered (Del g) | +1.9% | +6.3% | 5th lowest of 12 |
| Hurdle (Req g minus delivered) | +14.7 pp | -1.6 pp | 4th most demanding of 12 |
| ROIC minus cost of capital | -2.7 pp | -1.8 pp | 10th lowest of 21 |
| EV / EBITDA | 12.4× | 9.8× | 4th most expensive of 8 |
| Net debt / EBITDA | 0.7× | 0.4× | 4th most indebted of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Victrex VCT.L | United Kingdom | $1.06B | +46% | -1% | 14% | 22.5× | 16.7% | +1.9% |
| Metis TechBio 7666.HK | Hong Kong | $1.05B | -64% | +6,987% | -367% | n/a | n/a | n/a |
| Qingdao Huicheng Environmental Technology 300779.SZ | China | $1.08B | -48% | -13% | 5% | 69.5× | n/a | n/a |
| Jubilant Ingrevia JUBLINGREA.NS | India | $1.00B | -19% | +15% | 10% | 21.6× | 28.0% | +44.9% |
| Shanghai Emperor of Cleaning Hi-Tech 603200.SS | China | $1.12B | -24% | +4% | -8% | n/a | n/a | n/a |
| CNSIG Inner Mongolia Chemical Industry 600328.SS | China | $1.12B | -36% | -20% | -7% | n/a | n/a | n/a |
| Caregen 214370.KS | South Korea | $982M | -74% | -2% | 20% | 21.5× | 36.8% | +3.8% |
| Jinan Acetate Chemical 4763.TW | Taiwan | $1.14B | -5% | -24% | 43% | 6.6× | -20.2% | +41.2% |
| Dalian Bio-Chem 603360.SS | China | $971M | -54% | 0% | 16% | 21.7× | 8.5% | +18.4% |
| Hubei Jianghan New Materials 603281.SS | China | $1.15B | -38% | +8% | 17% | 21.1× | 3.9% | +6.3% |
| Raghav Productivity Enhancers RPEL.NS | India | $942M | +109% | +38% | 28% | n/a | n/a | n/a |
| Lanxess LXS.DE | Germany | $1.19B | -24% | -4% | 0% | n/a | 5.3% | -1.5% |
| Jilin Chemical Fibre Stock 000420.SZ | China | $1.20B | -34% | +11% | 5% | 130.4× | n/a | n/a |
| Jiangsu Zhengdan Chemical Industry 300641.SZ | China | $914M | -29% | -30% | 17% | n/a | 7.1% | +11.6% |
| Zhejiang Huangma Technology 603181.SS | China | $891M | -33% | +7% | 17% | 13.8× | n/a | n/a |
| Jiangsu Shuangxing Color Plastic New Materials 002585.SZ | China | $1.27B | -10% | -4% | -4% | 57.9× | 21.0% | +0.2% |
| Nippon Soda 4041.T | Japan | $1.29B | +11% | 0% | 10% | 12.2× | 5.2% | +1.8% |
| China Resources Chemical Innovative Materials 301090.SZ | China | $1.30B | -33% | +4% | 1% | 18.4× | 20.6% | +1.1% |
| Guangzhou Sanfu Newmaterials Technology 688359.SS | China | $832M | -54% | +8% | -7% | n/a | n/a | n/a |
| Rianlon 300596.SZ | China | $1.35B | -15% | +11% | 11% | 14.2× | n/a | n/a |
| Hanchem 014680.KS | South Korea | $1.35B | -49% | +11% | 17% | 11.6× | 5.8% | +7.4% |